Thiogenesis Therapeutics (TTI.V) Q4 2025 Earnings

26NovConfirmed
Q4 2024
Q2 2025
Q3 2025
Q4 2025
-0.05
-0.04
-0.04
-0.03

Details

Expected EPS
N/A
Actual EPS
-0.050395702
Surprise EPS
-0.05
Surprise Percent
+∞%

Description

Thiogenesis Therapeutics (TTI.V) has reported earnings of -0.050395702 per share for Q4 2025.

0 Comments

Share your thoughts